Cargando…

Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period

Studies observed that women infected with SARS-CoV-2 during pregnancy had a higher risk of preterm birth. Although it is likely that COVID-19 during the late trimester of pregnancy can trigger premature birth, prematurity remains a concern, and it is vital to study additional clinical and biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrubaru, Ingrid, Motoc, Andrei, Bratosin, Felix, Rosca, Ovidiu, Folescu, Roxana, Moise, Marius Liviu, Neagoe, Octavian, Citu, Ioana Mihaela, Feciche, Bogdan, Gorun, Florin, Erdelean, Dragos, Ratiu, Adrian, Citu, Cosmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694165/
https://www.ncbi.nlm.nih.gov/pubmed/36579593
http://dx.doi.org/10.3390/jpm12111871
_version_ 1784837730379759616
author Hrubaru, Ingrid
Motoc, Andrei
Bratosin, Felix
Rosca, Ovidiu
Folescu, Roxana
Moise, Marius Liviu
Neagoe, Octavian
Citu, Ioana Mihaela
Feciche, Bogdan
Gorun, Florin
Erdelean, Dragos
Ratiu, Adrian
Citu, Cosmin
author_facet Hrubaru, Ingrid
Motoc, Andrei
Bratosin, Felix
Rosca, Ovidiu
Folescu, Roxana
Moise, Marius Liviu
Neagoe, Octavian
Citu, Ioana Mihaela
Feciche, Bogdan
Gorun, Florin
Erdelean, Dragos
Ratiu, Adrian
Citu, Cosmin
author_sort Hrubaru, Ingrid
collection PubMed
description Studies observed that women infected with SARS-CoV-2 during pregnancy had a higher risk of preterm birth. Although it is likely that COVID-19 during the late trimester of pregnancy can trigger premature birth, prematurity remains a concern, and it is vital to study additional clinical and biological patient factors that are highly associated with this negative pregnancy outcome and allow for better management based on the existing predictors. In order to achieve this goal, the current study retrospectively recruited 428 pregnant patients that were separated into three study groups using a 1:2:4 matching ratio and a nearest-neighbor matching method. Sixty-one pregnant patients had a history of COVID-19 during pregnancy and gave birth prematurely; 124 pregnant patient controls had COVID-19 and gave birth full-term, while the second control group of 243 pregnant patients had a premature birth but no history of COVID-19. It was observed that a symptomatic SARS-CoV-2 infection during the third trimester was significantly more likely to be associated with premature birth. Even though the rate of ICU admission was higher in these cases, the mortality rate did not change significantly in the COVID-19 groups. However, SARS-CoV-2 infection alone did not show statistical significance in determining a premature birth (β = 1.09, CI = 0.94–1.15, p-value = 0.067). Maternal anemia was the strongest predictor for prematurity in association with SARS-CoV-2 infection (β = 3.65, CI = 1.46–5.39, p-value < 0.001), followed by elevated CRP (β = 2.11, CI = 1.20–3.06, p-value < 0.001), and respectively IL-6 (β = 1.92, CI = 1.20–2.47, p-value = 0.001. SARS-CoV-2 infection is associated with an increased risk of preterm birth, as shown by our data. If SARS-CoV-2 infection arises during the third trimester, it is recommended that these patients be hospitalized for surveillance of clinical evolution and biological parameters, such as anemia and high inflammatory markers, which have a multiplicative influence on the pregnancy result.
format Online
Article
Text
id pubmed-9694165
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96941652022-11-26 Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period Hrubaru, Ingrid Motoc, Andrei Bratosin, Felix Rosca, Ovidiu Folescu, Roxana Moise, Marius Liviu Neagoe, Octavian Citu, Ioana Mihaela Feciche, Bogdan Gorun, Florin Erdelean, Dragos Ratiu, Adrian Citu, Cosmin J Pers Med Article Studies observed that women infected with SARS-CoV-2 during pregnancy had a higher risk of preterm birth. Although it is likely that COVID-19 during the late trimester of pregnancy can trigger premature birth, prematurity remains a concern, and it is vital to study additional clinical and biological patient factors that are highly associated with this negative pregnancy outcome and allow for better management based on the existing predictors. In order to achieve this goal, the current study retrospectively recruited 428 pregnant patients that were separated into three study groups using a 1:2:4 matching ratio and a nearest-neighbor matching method. Sixty-one pregnant patients had a history of COVID-19 during pregnancy and gave birth prematurely; 124 pregnant patient controls had COVID-19 and gave birth full-term, while the second control group of 243 pregnant patients had a premature birth but no history of COVID-19. It was observed that a symptomatic SARS-CoV-2 infection during the third trimester was significantly more likely to be associated with premature birth. Even though the rate of ICU admission was higher in these cases, the mortality rate did not change significantly in the COVID-19 groups. However, SARS-CoV-2 infection alone did not show statistical significance in determining a premature birth (β = 1.09, CI = 0.94–1.15, p-value = 0.067). Maternal anemia was the strongest predictor for prematurity in association with SARS-CoV-2 infection (β = 3.65, CI = 1.46–5.39, p-value < 0.001), followed by elevated CRP (β = 2.11, CI = 1.20–3.06, p-value < 0.001), and respectively IL-6 (β = 1.92, CI = 1.20–2.47, p-value = 0.001. SARS-CoV-2 infection is associated with an increased risk of preterm birth, as shown by our data. If SARS-CoV-2 infection arises during the third trimester, it is recommended that these patients be hospitalized for surveillance of clinical evolution and biological parameters, such as anemia and high inflammatory markers, which have a multiplicative influence on the pregnancy result. MDPI 2022-11-08 /pmc/articles/PMC9694165/ /pubmed/36579593 http://dx.doi.org/10.3390/jpm12111871 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hrubaru, Ingrid
Motoc, Andrei
Bratosin, Felix
Rosca, Ovidiu
Folescu, Roxana
Moise, Marius Liviu
Neagoe, Octavian
Citu, Ioana Mihaela
Feciche, Bogdan
Gorun, Florin
Erdelean, Dragos
Ratiu, Adrian
Citu, Cosmin
Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title_full Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title_fullStr Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title_full_unstemmed Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title_short Exploring Clinical and Biological Features of Premature Births among Pregnant Women with SARS-CoV-2 Infection during the Pregnancy Period
title_sort exploring clinical and biological features of premature births among pregnant women with sars-cov-2 infection during the pregnancy period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694165/
https://www.ncbi.nlm.nih.gov/pubmed/36579593
http://dx.doi.org/10.3390/jpm12111871
work_keys_str_mv AT hrubaruingrid exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT motocandrei exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT bratosinfelix exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT roscaovidiu exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT folescuroxana exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT moisemariusliviu exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT neagoeoctavian exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT cituioanamihaela exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT fecichebogdan exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT gorunflorin exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT erdeleandragos exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT ratiuadrian exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod
AT citucosmin exploringclinicalandbiologicalfeaturesofprematurebirthsamongpregnantwomenwithsarscov2infectionduringthepregnancyperiod